The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update Issue 11 (PDF).
This issue includes the following drug safety advice articles:
- Natalizumab (Tysabri): safety overview—progressive multifocal leukoencephalopathy, hypersensitivity, and hepatotoxicity
- Nicorandil: gastrointestinal ulceration
In addition, this issue contains a hot topic containing information about
recent data from the ENHANCE trial and also a stop press warning that several herbal products available for erectile dysfunction have been found to contain prescription only drugs including oral hypoglycaemic agents.
Action: Clinicians will find this publication to be a useful review of current issues in drug safety.
|« Quadrivalent HPV protects against VaIN||IHD and HDL relationship queried »|